Related Experiment Video
Updated: Aug 15, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity
Matthias G von Herrath1, Gerald T Nepom
1La Jolla Institute for Allergy and Immunology, San Diego, CA 92109, USA. Matthias@liai.org
Abstract:
Induction of selective, autoantigen-specific tolerance is the "holy grail" for the treatment and prevention of autoimmune diseases. Despite successes in many differential murine models, rational and efficient translation to the clinic has been difficult. During the 5th Annual Federation of Clinical Immunological Societies (FOCIS) Meeting, May 12-16, 2005, in Boston, MA, a Kirin-sponsored "Ideashop" was convened to discuss this theme amongst scientists, clinicians, industry partners, and funding agencies.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Tumor Immunotherapy
Cell-mediated Immune Responses
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...

